This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Hk Inno.n Corporation. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Jiwon Choi: Innovator in Pharmaceutical Chemistry
Introduction
Jiwon Choi is a prominent inventor based in Icheon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on innovative solutions for treating diseases, showcasing his dedication to advancing healthcare.
Latest Patents
Jiwon Choi holds a patent for N-(isopropyl-triazolyl)pyridinyl)-heteroaryl-carboxamide derivatives and their use. This patent describes novel compounds that can be utilized for preventing or treating diseases mediated by ASK-1, with the compounds serving as active ingredients. The patent highlights the preparation methods and potential therapeutic applications of these derivatives, emphasizing their importance in medical research.
Career Highlights
Throughout his career, Jiwon Choi has been associated with Hk Inno.n Corporation, where he has contributed to various research projects. His expertise in pharmaceutical chemistry has enabled him to develop innovative solutions that address critical health challenges. His work has garnered attention in the scientific community, reflecting his commitment to improving patient outcomes.
Collaborations
Jiwon Choi has collaborated with notable colleagues, including Dongkyu Kim and Seungin Kim. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Jiwon Choi is a dedicated inventor whose work in pharmaceutical chemistry has the potential to transform medical treatments. His innovative approach and commitment to research continue to drive advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile